Literature DB >> 28074534

Depolarizing γ-aminobutyric acid contributes to glutamatergic network rewiring in epilepsy.

Nazim Kourdougli1,2, Christophe Pellegrino1,2, Juho-Matti Renko3, Stanislav Khirug4, Geneviève Chazal1,2, Tiina-Kaisa Kukko-Lukjanov4, Sari E Lauri4, Jean-Luc Gaiarsa1,2, Liang Zhou4, Angélique Peret1,2, Eero Castrén4, Raimo K Tuominen3, Valérie Crépel1,2, Claudio Rivera1,2,4.   

Abstract

OBJECTIVE: Rewiring of excitatory glutamatergic neuronal circuits is a major abnormality in epilepsy. Besides the rewiring of excitatory circuits, an abnormal depolarizing γ-aminobutyric acidergic (GABAergic) drive has been hypothesized to participate in the epileptogenic processes. However, a remaining clinically relevant question is whether early post-status epilepticus (SE) evoked chloride dysregulation is important for the remodeling of aberrant glutamatergic neuronal circuits.
METHODS: Osmotic minipumps were used to infuse intracerebrally a specific inhibitor of depolarizing GABAergic transmission as well as a functionally blocking antibody toward the pan-neurotrophin receptor p75 (p75NTR ). The compounds were infused between 2 and 5 days after pilocarpine-induced SE. Immunohistochemistry for NKCC1, KCC2, and ectopic recurrent mossy fiber (rMF) sprouting as well as telemetric electroencephalographic and electrophysiological recordings were performed at day 5 and 2 months post-SE.
RESULTS: Blockade of NKCC1 after SE with the specific inhibitor bumetanide restored NKCC1 and KCC2 expression, normalized chloride homeostasis, and significantly reduced the glutamatergic rMF sprouting within the dentate gyrus. This mechanism partially involves p75NTR signaling, as bumetanide application reduced SE-induced p75NTR expression and functional blockade of p75NTR decreased rMF sprouting. The early transient (3 days) post-SE infusion of bumetanide reduced rMF sprouting and recurrent seizures in the chronic epileptic phase.
INTERPRETATION: Our findings show that early post-SE abnormal depolarizing GABA and p75NTR signaling fosters a long-lasting rearrangement of glutamatergic network that contributes to the epileptogenic process. This finding defines promising and novel targets to constrain reactive glutamatergic network rewiring in adult epilepsy. Ann Neurol 2017;81:251-265.
© 2017 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28074534     DOI: 10.1002/ana.24870

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Short-Term Depression of Sprouted Mossy Fiber Synapses from Adult-Born Granule Cells.

Authors:  William D Hendricks; Yang Chen; AeSoon L Bensen; Gary L Westbrook; Eric Schnell
Journal:  J Neurosci       Date:  2017-05-11       Impact factor: 6.167

2.  Preventing neuronal edema increases network excitability after traumatic brain injury.

Authors:  Punam A Sawant-Pokam; Tyler J Vail; Cameron S Metcalf; Jamie L Maguire; Thomas O McKean; Nick O McKean; K C Brennan
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Mechanism of BDNF Modulation in GABAergic Synaptic Transmission in Healthy and Disease Brains.

Authors:  Christophe Porcher; Igor Medina; Jean-Luc Gaiarsa
Journal:  Front Cell Neurosci       Date:  2018-08-28       Impact factor: 5.505

Review 4.  Off-Label Use of Bumetanide for Brain Disorders: An Overview.

Authors:  Shivani C Kharod; Seok Kyu Kang; Shilpa D Kadam
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

Review 5.  Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function.

Authors:  Ru Liu; Junling Wang; Shuli Liang; Guojun Zhang; Xiaofeng Yang
Journal:  Front Neurol       Date:  2020-01-17       Impact factor: 4.003

6.  Protective Role of Low Ethanol Administration Following Ischemic Stroke via Recovery of KCC2 and p75NTR Expression.

Authors:  Stanislav Khirug; Shetal Soni; Marta Saez Garcia; Marine Tessier; Liang Zhou; Natalia Kulesskaya; Heikki Rauvala; Dan Lindholm; Anastasia Ludwig; Florence Molinari; Claudio Rivera
Journal:  Mol Neurobiol       Date:  2020-10-24       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.